www.mhlw.go.jp/stf/newpage_27695.html
archives
This URL has 1 public saves. The first save was Apr 9, 2026, 12:01 PM and the latest save was Apr 9, 2026, 12:01 PM.
View recent saves on this domain
Latest saved version
新型コロナウイルス治療薬の特例承認について｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/newpage_27695.html
About this page
This page announces the special approval of a COVID-19 therapeutic drug by Japan's Ministry of Health, Labour and Welfare on August 30, 2022. Under the Pharmaceutical Affairs Law, "Evusheld Intramuscular Injection Set" (tixagevimab and cilgavimab) submitted by AstraZeneca was approved. The drug is used for treating SARS-CoV-2 infection and preventing its onset. The application was filed on June 9, 2022, with attached documents available separately.
Saved versions
www.mhlw.go.jp/stf/newpage_27695.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.